Patient safety advocates join NPSF governing boards


The National Patient Safety Foundation (NPSF), a central voice for patient safety since 1997, has made new appointments to the Foundation's board of directors and board of advisors.

Joining the NPSF board of directors for a term of three years are John Castellani, president and chief executive officer (CEO), PhRMA (the Pharmaceutical Research and Manufacturers of America), and Peter Aranow, a private investor based in Uxbridge, Massachusetts.

Newly appointed to two-year terms on the NPSF board of advisors are Jeffrey Catalano, partner, Todd & Weld; Tracey Moorhead, president and CEO, Visiting Nurse Associations of America (VNAA); and Stephen Littlejohn, president, Climb the Curve Communications. 

Dr Charles Benda, a long-time member of the NPSF board of directors, moves to the board of advisors.

"We at NPSF are extremely pleased to be welcoming these new board members, who bring a diverse range of experiences and backgrounds, but who all share a commitment to advancing the cause of safer patient care," said Dr Tejal Gandhi, president of NPSF. "We are very much looking forward to working with them on advancing the Foundation's mission."

The NPSF board of directors provides strategic and operational oversight and is vested with fiduciary responsibilities for the Foundation. The NPSF board of advisors (formerly known as the board of governors) offers advisory direction and insight on NPSF program development, in keeping with the Foundation's mission. 

Dr Gregg Meyer, chief clinical officer, Partners HealthCare, is the current chair of the board of directors. Dr Jane Englebright, chief nurse executive, patient safety officer, and senior vice president, Clinical Services Group, Hospital Corporation of America, currently chairs the board of advisors.

"I know the other members of the NPSF boards join me in enthusiastically welcoming the new members," said Dr Meyer. "This is an exciting time for the Foundation, and our nominating committee did an outstanding job of ensuring that the boards are characterized by a wide range of expertise."

National Patient Safety Foundation, NPSF, US, John Castellani, PhRMA, Peter Aranow